Pathkey.AI Ltd

Healthcare • Health Information Services • Quote as of 10/28/2026 15:51

Company Profile

IndustryHealth Information Services

SectorHealthcare

Market Capitalization21.63 mln

Float1,338 mln

Earnings Date03/04/2027

Piotroski F-Score

4 / 9

Borderline

Beneish M-Score

92031

Highly suspicious

1-Year Forecast

0.15

Transformational upside

Relative Strength

10 / 100

Significantly lagging

Pre-Tax Margin

-8,106%

Severely loss-making

ROE

-18.10

Negative

Business Description

Pathkey.AI Ltd is a Sydney-based digital health company that uses artificial intelligence to improve how clinical trials are designed and to better predict patient outcomes across Australia. Its two main products, TrialKey and TrialGen, help biopharma, MedTech, and healthcare organizations run smarter, more efficient trials. Founded in 1994 and formerly known as Opyl Limited, the company rebranded to Pathkey.AI Ltd in August 2025.

Key Fundamentals

EPS-0.01

ROE-18.10

RPS0.00

ROIC-19.87

ROA-17.73

Interest Cover-286

EBITDA, mln-3.84

EV / EBITDA4.35

EV / EBIT4.35

Revenue, mln0.05

EV / Revenue333

Quote Details

Last 0.016

Change 0.001 (6.67%)

Open 0.016

Volume 1,642,057

Turnover 26,273

Average Volume 1,481,143

Financial Ratios

Pre-Tax Profit Margin-8,106

Leverage Ratio1.01

Current Ratio7.59

Price / Book0.82

Price / Sales454

PEG Ratio1.76

Financial Strength

Altman Z-Score43.6

Piotroski F-Score 4 / 9

Beneish M-Score92031

Price to Intrinsic Value0.87

1-Year Target Price0.15

Price Performance & Relative Strength

Period	Price Performance	Relative Strength
1 Week	-11.11%	9 / 100
1 Month	-40.74%	2 / 100
2 Months	-57.89%	1 / 100
6 Months	-69.23%	2 / 100
1 Year	-36%	26 / 100